RxDoctor Payments DataLook up a doctor →

Barry Singer

Neurology · Saint Louis, MONPI 1932210671

Payments from drug & device makers

$3,336,220in general payments, 2019–2025

Across 1,890 payments — averaging $1765.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$655K
  • Sanofi$534K
  • Biogen$451K
  • TG Therapeutics, Inc.$366K
  • Novartis$336K
  • EMD Serono, Inc.$256K
  • plus $740K from 33 others
$39,711in research payments, 2019–2025

Across 50 payments — averaging $794.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$28K
  • Sanofi$12K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,336,220 in reported general payments places this provider in the 95th percentile of 381 neurology providers in Missouri.

See all neurology providers in Missouri

Medicare billing

Part B allowed, 2024
$85,777
Medicare patients
335
Services billed
785

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →